Erratum: Feelings of hopelessness in midlife and cognitive health in later life: A prospective population-based cohort study (PLoS ONE ()2015 10:10 (e0140261) DOI: 10.1371/journal.pone.0140261);Feelings of hopelessness in midlife and cognitive health in later life: A prospective population-based cohort study

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Håkansson, Krister ^a,b   Soininen, Hilkka ^c   Winblad, Bengt ^a   Kivipelto, Miia ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ARTICLE; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FINLAND; FOLLOW UP; HOPELESSNESS; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; ADULT; COGNITION DISORDERS; COMPLICATION; EMOTION; GENETICS; HETEROZYGOTE; MIDDLE AGED;

ADULT; APOLIPOPROTEIN E4; COGNITION; COGNITION DISORDERS; DEPRESSION; EMOTIONS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84948757488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142465     Document Type: Erratum

References (45)

1. Amieva H, Le Goff M, Millet X, Orgogozo J-M, Pérès K, Barberger-Gateau P, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Annals of Neurology. 2008;64:492-498. doi: 10.1002/ana.21509 PMID: 19067364
2. Devanand DP, Sano M, Tang M-X, Taylor S, Gurland BJ, Wilder D, et al. Depressed Mood and the Incidence of Alzheimer's Disease in the Elderly Living in the Community. Archives of General Psychiatry. American Medical Association; 1996;53:175-182. doi: 10.1001/archpsyc.1996.01830020093011 PMID: 8629893
3. Luchsinger J, Honig L, Tang M, Devanand D. Depressive symptoms, vascular risk factors, and Alzheimer's disease. Int J Geriatr Psychiatry. 2008;23:922-928. doi: 10.1002/gps.2006 PMID: 18327871
4. Andersen K, Lolk A, Kragh-Sorensen P, Petersen N, Green A. Depression and the risk of Alzheimer disease. Epidemiology. 2005;16:233-238. doi: 10.1097/01.ede.0000152116.32580.24 PMID: 15703539
5. Modrego PJ, Ferrández J. Depression in Patients With Mild Cognitive Impairment Increases the Risk of Developing Dementia of Alzheimer Type: A Prospective Cohort Study. Arch Neurol. American Medical Association; 2004;61:1290-1293. doi: 10.1001/archneur.61.8.1290 PMID: 15313849
6. Wilson R, Barnes L, de Leon C, Aggarwal N, Schneider J, Bach J, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002;59:364-370. doi: http://dx.doi.org/10. 1212/WNL.59.3.364 PMID: 12177369
7. Palmer K, Berger A, Monastero R, Winblad B, Bachman L, Fratiglioni L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology. 2007;68:1596-1602. doi: http://dx.doi.org/10.1212/01.wnl.0000260968.92345.3f PMID: 17485646
8. Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R. Depressive symptoms and risk of dementia: The Framingham Heart Study. Neurology. 2010;75:35-41. doi: 10.1212/WNL. 0b013e3181e62138 PMID: 20603483
9. Dal Forno G, Palermo MT, Donohue JE, Karagiozis H, Zonderman AB, Kawas CH. Depressive symptoms, sex, and risk for Alzheimer's disease. Annals of Neurology. 2005;57:381-387. doi: 10.1002/ana. 20405 PMID: 15732103
10. Geerlings MI, Heijer den T, Koudstaal PJ, Hofman A, Breteler MMB. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology. 2008;70:1258-1264. doi: 10.1212/01.wnl.0000308937.30473.d1 PMID: 18391157
11. Deckers K, van Boxtel MPJ, Schiepers OJG, de Vugt M, Muñoz Sánchez JL, Anstey KJ, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry. 2015;30:234-246. doi: 10.1002/gps.4245 PMID: 25504093
12. Wilson RS, Arnold SE, Beck TL, Bienias JL, Bennett DA. Change in depressive symptoms during the prodromal phase of Alzheimer disease. Archives of General Psychiatry. 2008;65:439-445. doi: 10. 1001/archpsyc.65.4.439 PMID: 18391132
13. Wilson RS, Hoganson GM, Rajan KB, Barnes LL, Mendes de Leon CF, Evans DA. Temporal course of depressive symptoms during the development of Alzheimer disease. Neurology. 2010;75:21-26. doi: 10.1212/WNL.0b013e3181e620c5 PMID: 20603481
14. Barnes DED, Yaffe KK, Byers ALA, McCormick MM, Schaefer CC, Whitmer RAR. Midlife vs Late-Life Depressive Symptoms and Risk of Dementia: Differential Effects for Alzheimer Disease and Vascular Dementia. Archives of General Psychiatry. 2012;69:493-498. doi: 10.1001/archgenpsychiatry.2011. 1481 PMID: 22566581
15. Beck A, Weissman A, Lester D, Trexler L. Measurement of Pessimism-Hopelessness Scale. J Consult Clin Psych. 1974;42:861-865.
16. Beck AT, Wenzel A, Riskind JH, Brown G, Steer RA. Specificity of Hopelessness about Resolving Life Problems: Another Test of the Cognitive Model of Depression. Cognitive Therapy and Research. 2006;30:773-781. doi: 10.1007/s10608-006-9081-2
17. Beck AT, Steer RA, Kovacs M, Garrison B. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. American Journal of Psychiatry. 1985;142:559-563. PMID: 3985195
18. Zhang J, Li Z. The association between depression and suicide when hopelessness is controlled for. Compr Psychiatry. 2013;54:790-796. doi: 10.1016/j.comppsych.2013.03.004 PMID: 23602028
19. Hawton K, Casanas ICC, Haw C, Saunders K. Risk factors for suicide in individuals with depression: a systematic review. Journal of Affective Disorders. 2013 ed. 2013;147:17-28. doi: 10.1016/j.jad.2013. 01.004 PMID: 23411024
20. Stamatakis KA, Lynch J, Everson SA, Raghunathan T, Salonen JT, Kaplan GA. Self-esteem and mortality: prospective evidence from a population-based study. Annals of Epidemiology. 2004;14:58-65. doi: 10.1016/S1047-2797 (03) 00078-4 PMID: 14664781
21. Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A, et al. Depressed Affect, Hopelessness, and the Risk of Ischemic-Heart-Disease in a Cohort of United-States Adults. Epidemiology. 1993;4:285-293. PMID: 8347738
22. Everson S, Goldberg D, Kaplan G, Cohen R, Pukkala E, Tuomilehto J, et al. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosomatic Medicine. 1996;58:113-121. PMID: 8849626
23. Boyle PA, Buchman AS, Barnes LL, Bennett DA. Effect of a Purpose in Life on Risk of Incident Alzheimer Disease and Mild Cognitive Impairment in Community-Dwelling Older PersonsLife Purpose and AD Risk. Archives of General Psychiatry. American Medical Association; 2010;67:304-310. doi: 10. 1001/archgenpsychiatry.2009.208 PMID: 20194831
24. Geda YE, Roberts RO, Mielke MM, Knopman DS, Christianson TJH, Pankratz VS, et al. Baseline Neuropsychiatric Symptoms and the Risk of Incident Mild Cognitive Impairment: A Population-Based Study. Am J Psychiatry. 2014.
25. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland, 1972-1997. International Journal of Epidemiology. 2000;29:49-56. PMID: 10750603
26. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, et al. Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med. 1993;121:598-602. PMID: 8095964
27. Folstein M, Folstein S, McHugh P. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198. PMID: 1202204
28. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944. PMID: 6610841
29. Petersen R, Smith G, Ivnik R, Tangalos E, Schaid D, Thibodeau S, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273:1274-1278. PMID: 7646655
30. Radloff LS. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement. 1977;1:385-401.
31. Wolfson C, Wolfson D, Asgharian M, M'Lan C, Ostbye T, Rockwood K, et al. A reevaluation of the duration of survival after the onset of dementia. New England Journal of Medicine. 2001;344:1111-1116. PMID: 11297701
32. Walsh JS, Welch HG, Larson EB. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med. 1990 ed. 1990;113:429-434. PMID: 2386336
33. Hammar A, Ardal G. Cognitive functioning in major depression-a summary. Front Hum Neurosci. 2009;3:26. doi: 10.3389/neuro.09.026.2009 PMID: 19826496
34. Lupien SJ, Nair NP, Brière S, Maheu F, Tu MT, Lemay M, et al. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Reviews in the Neurosciences. 1999;10:117-139. PMID: 10658955
35. Soetanto A, Wilson RS, Talbot K, Un A, Schneider JA, Sobiesk M, et al. Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Archives of General Psychiatry. 2010 ed. 2010;67:448-457. doi: 10.1001/archgenpsychiatry.2010.48 PMID: 20439826
36. Swaab D, Bao A-M, Lucassen P. The stress system in the human brain in depression and neurodegeneration. Ageing Research Reviews. 2005;4:141-194. PMID: 15996533
37. Bao A, Meynen G, Swaab D. The stress system in depression and neurodegeneration: Focus on the human hypothalamus. Brain Research Reviews. 2008;57:531-553. PMID: 17524488
38. Dobos N, Korf J, Luiten PGM, Eisel ULM. Neuroinflammation in Alzheimer's disease and major depression. Biological Psychiatry. 2010;67:503-504. doi: 10.1016/j.biopsych.2010.01.023 PMID: 20185031
39. Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7:323-331. doi: 10.1038/nrneurol.2011.60 PMID: 21537355
40. Ashford JW. APOE genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci. Humana Press; 2004;23:157-165. doi: 10.1385/JMN:23:3:157 PMID: 15181244
41. Kivipelto M, Rovio S, Ngandu T, Kåreholt I, Eskelinen M, Winblad B, et al. Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med. 2008;12:2762-2771. doi: 10.1111/j.1582-4934.2008.00296.x PMID: 18318693
42. Hakansson K, Rovio S, Helkala E-L, Vilska A-R, Winblad B, Soininen H, et al. Association between mid-life marital status and cognitive function in later life: population based cohort study. Brit Med J. 2009;339:b2462. doi: 10.1136/bmj.b2462 PMID: 19574312
43. Karlsson IK, Bennet AM, Ploner A, Andersson TM-L, Reynolds CA, Gatz M, et al. Apolipoprotein E ε4 genotype and the temporal relationship between depression and dementia. Neurobiol Aging. 2015;36:1751-1756. doi: 10.1016/j.neurobiolaging.2015.01.008 PMID: 25670333
44. Prigerson H, Bierhals A, Kasl S, Reynolds C, Shear M, Day N, et al. Traumatic grief as a risk factor for mental and physical morbidity. American Journal of Psychiatry. 1997;154:616-623. PMID: 9137115
45. Irwin M. Psychoneuroimmunology of depression: Clinical implications. Brain Behav Immun. 2002;16:1-16. doi: 10.1006/brbi.2001.0654 PMID: 11846437